|
|
.
See Category: Diseases of the nervous system
See Header: Other epilepsy
ICD-10 (CM) Code and Descriptor
|
G40.801 |
Other epilepsy, not intractable, with status epilepticus
|
G40801 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 35.70%
|
9.98%
|
14.37%
|
7.11%
|
6.96%
|
13.31%
|
3.93%
|
3.33%
|
1.97%
|
0.45%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G40.801*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
97530
|
THERAPEUTIC ACTIVITIES |
371
|
720
|
|
97110
|
THERAPEUTIC EXERCISES |
261
|
379
|
|
97535
|
SELF CARE MNGMENT TRAINING |
131
|
250
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
113
|
113
|
|
97116
|
GAIT TRAINING THERAPY |
94
|
147
|
|
80053
|
COMPREHEN METABOLIC PANEL |
92
|
92
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
83
|
85
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
80
|
117
|
|
71045
|
X-RAY EXAM CHEST 1 VIEW |
61
|
64
|
|
J2060
|
LORAZEPAM INJECTION |
56
|
82
|
|
70450
|
CT HEAD/BRAIN W/O DYE |
53
|
53
|
|
83735
|
ASSAY OF MAGNESIUM |
51
|
51
|
|
92526
|
ORAL FUNCTION THERAPY |
50
|
50
|
|
J1953
|
LEVETIRACETAM INJECTION |
48
|
7,256
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
45
|
98
|
|
93005
|
ELECTROCARDIOGRAM TRACING |
43
|
47
|
|
83605
|
ASSAY OF LACTIC ACID |
40
|
45
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
37
|
37
|
|
80048
|
METABOLIC PANEL TOTAL CA |
37
|
37
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
37
|
37
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G40.801 related to the following DRG Codes:
023
100-101
|
